21 CFR 1107.20
§ 1107.20 Amendments.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 1107.20, § 1107.20 Amendments, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91516
- Permanent ID
ys:prov:91516@1- SHA-256
efb000d5bbd65acd1a2db93fe5157fdd2ef32842303b089bbbf0f104a3d5bb3a
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Except as provided in paragraphs (b) and (c) of this section, the applicant may submit an amendment to an SE Report in accordance with subpart C of this part. If an applicant chose to submit a health information summary with its SE Report under § 1107.18(j)(1), the applicant must submit with the amendment a redacted copy of the amendment that excludes research subject identifiers and trade secret and confidential commercial information as defined in §§ 20.61 and 20.63 of this chapter.
(b) An applicant may not amend an SE Report to change the predicate tobacco product.
(c) An applicant may not amend an SE Report after FDA has closed the SE Report under § 1107.44 or it has been withdrawn under § 1107.22.
(d) In general, amendments will be reviewed in the next review cycle as described in § 1107.42.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.